ANGPTL6 ELISA Kit
-
- Target Alle ANGPTL6 ELISA Kits anzeigen
- ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))
-
Reaktivität
- Human
- Nachweismethode
- Colorimetric
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 1.56-100 ng/mL
- Untere Nachweisgrenze
- 1.56 ng/mL
- Applikation
- ELISA
- Proben
- Cell Culture Supernatant, Plasma, Serum
- Analytische Methode
- Quantitative
- Spezifität
- Detects human ANGPTL6.
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Does not cross-react with human ANGPTL3, human ANGPTL4 or human ANGPTL7.
- Sensitivität
- 1.2 ng/mL
- Produktmerkmale
- ANGPTL6 (human) ELISA Kit
- Featured
- Zu unserem meistverkauften ANGPTL6 ELISA Kit
- Top Product
- Discover our top product ANGPTL6 ELISA Kit
-
-
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: +4°C
-
- Target Alle ANGPTL6 ELISA Kits anzeigen
- ANGPTL6 (Angiopoietin-Like 6 (ANGPTL6))
- Andere Bezeichnung
- ANGPTL6 (ANGPTL6 Produkte)
- Synonyme
- AGF ELISA Kit, ARP5 ELISA Kit, 6330404E11Rik ELISA Kit, ARP3 ELISA Kit, Arp5 ELISA Kit, cb242 ELISA Kit, sb:cb242 ELISA Kit, ACTR3 ELISA Kit, angiopoietin like 6 ELISA Kit, angiopoietin-like 6 ELISA Kit, ARP3 actin related protein 3 homolog ELISA Kit, ANGPTL6 ELISA Kit, Angptl6 ELISA Kit, angptl6 ELISA Kit, ACTR3 ELISA Kit
- Hintergrund
- Seven proteins containing an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain, both characteristics of angiopoietins, have been identified and therefore designated angiopoietin-like proteins 1-7 (ANGPTL 1-7). ANGPTL3 and ANGPTL6 (Angiopoietin-related growth factor, AGF), among others, function to regulate angiogenesis and also appear to directly regulate lipid, glucose and energy metabolism. The serum levels of ANGPTL6 are significantly increased in obese humans, patients with type 2 diabetes mellitus (T2DM) and in metabolic syndrome. Therefore, ANGPTL6 may be a novel biomarker for metabolic diseases and may provide a novel therapeutic approach to counteract obesity, T2DM and insulin resistance.
- UniProt
- Q8NI99
- Pathways
- Regulation of Actin Filament Polymerization
-